MorphoSys AG buy systinvest
Start price
23.12.21
/
50%
€33.28
Target price
23.12.22
-
Performance (%)
-41.87%
End price
25.08.22
€19.35
Summary
This prediction ended on 25.08.22 with a price of €19.35. Massive losses of -41.87% were the result for the BUY prediction by systinvest. systinvest has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| MorphoSys AG | 0.148% | 0.148% | 245.840% |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% |
Comments by systinvest for this prediction
In the thread Morphosys AG diskutieren
systinvest bought the security MorphoSys AG in his wikifolio Aktienwertselektion mit System.